NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
December 2, 2025 — Soligenix develops HyBryte™ for rare diseases as aging population faces healthcare challenges. Learn about medical innovation addressing unmet needs in chronic conditions.
December 2, 2025 — ABVC BioPharma highlights safety of plant-based ADHD drug ABV-1505 amid concerns about psychiatric polypharmacy. Non-stimulant alternative shows promise in clinical trials.
December 2, 2025 — CTT Pharma CEO outlines 2026 manufacturing plans for micelle thin-film drug delivery technology, including SEC reporting status and NIH partnership updates.
December 1, 2025 — Quantum BioPharma's $700M lawsuit against CIBC and RBC over stock spoofing allegations featured in CTV W5 investigation, impacting Lucid-MS multiple sclerosis treatment development.
December 1, 2025 — HeartBeam faces FDA decision on 12-lead ECG software but sees path forward. Medical tech company developing revolutionary 3D cardiac monitoring technology for portable use.
December 1, 2025 — Soligenix completes enrollment for Phase 3 FLASH2 trial of HyBryte™ for cutaneous T-cell lymphoma (CTCL), a key step toward potential FDA approval of a novel photodynamic therapy.
December 1, 2025 — NanoViricides signs agreement with Only Orphans Cote to pursue orphan drug designations for NV-387, targeting Smallpox and MPox with potential FDA incentives.
December 1, 2025 — Quantum BioPharma's $700M lawsuit against CIBC and RBC over alleged stock spoofing featured in CTV W5 investigation. Company continues advancing Lucid-MS multiple sclerosis treatment amid market manipulation claims.
December 1, 2025 — HeartBeam details FDA strategy for 12-lead ECG software after Not Substantially Equivalent decision. Company pursuing appeal path for breakthrough cardiac monitoring technology.
December 1, 2025 — New study reveals how metabolic conditions like obesity accelerate cognitive decline and Alzheimer's risk. Research highlights chronic inflammation's role and boosts biomedical companies developing solutions.
December 1, 2025 — Quantum BioPharma files $700M lawsuit against CIBC and RBC over stock spoofing allegations while advancing MS research. CTV News investigates market manipulation claims.
December 1, 2025 — Maho & Prentice, LLP releases a vital guide on 5 steps to take after a car accident in California. Learn how to protect your health, rights, and recovery potential.
December 1, 2025 — Dr. Muhamad Aly Rifai's book "Doctor Not Guilty" is a #1 Amazon bestseller detailing his acquittal in a federal fraud case. It explores healthcare overcriminalization.
November 30, 2025 — Creative Biogene launches custom RNA services including mRNA, circRNA & RNAi synthesis. Advanced CDMO platform with LNP technology accelerates RNA drug development.
November 30, 2025 — Creative Bioarray launches innovative in vitro metabolic assay kits for drug development research. New kits provide customizable protocols for studying drug metabolism pathways with unprecedented precision.
November 28, 2025 — Soligenix develops thermostable vaccines stable for 2+ years at 40°C using ThermoVax platform. Breakthrough eliminates cold chain needs for Ebola/Marburg vaccines.
November 28, 2025 — Tianjin University researchers reveal ultrasound-activated drug delivery systems using polymer mechanochemistry for precise cancer treatment with reduced side effects.
November 27, 2025 — Researchers develop persistent luminescence nanoparticle probe for hydrogen peroxide detection that eliminates autofluorescence interference. Enables naked-eye visualization and instrument-free monitoring in food and consumer products.
November 27, 2025 — Study reveals mirror-image pesticide forms affect fish differently across generations. S-enantiomer accumulates more, causes developmental defects & endocrine disruption in offspring. Research challenges current environmental assessment methods.
November 26, 2025 — Nano-X Imaging raises $15M in direct offering to advance AI-powered medical imaging technology. Learn how Nanox aims to revolutionize preventive healthcare worldwide.